Literature DB >> 6776807

Pulmonary manifestations of Waldenstrom macroglobulinemia.

P G Rausch, J C Herion.   

Abstract

Waldenstrom macroglobulinemia (WMG), a proliferation of malignant monoclonal IgM secreting plasmacytoid lymphocytes in lymph nodes, spleen, and marrow, usually pursues a chronic clinical course. A patient with WMG for five years who developed pulmonary tumors consisting of plasmacytoid lymphocytes prompted a review of the literature for pulmonary manifestations of WMG. Twenty-six males and 18 females, ranging in age from 33 to 84 years, have been reported with histologically proven pulmonary involvement by WMG. The x-ray findings, evident in most patients when first seen, consisted of masses (22 patients), inflitrates (31 patients), and pleural effusions (19 patients). Most patients (24) had two or more of these manifestations but only five, in addition to our patient, had isolated pulmonary nodules. Isolated pulmonary infiltrates were found in ten patients and isolated pleural effusions in only four. Symptoms at the onset of pulmonary involvement included dyspnea (54%), nonproductive cough (33%), and chest pain (7%); 15% were asymptomatic. Pulmonary manifestations, like other features of WMG, respond to alkylating agents or irradiation and do not appear to affect prognosis adversely. Pulmonary involvement should be suspected in any patient with WMG who develops an abnormal chest x-ray.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776807     DOI: 10.1002/ajh.2830090208

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

1.  Bronchoalveolar lavage in Waldenström's macroglobulinaemia with pulmonary infiltrates.

Authors:  R B Filuk; P W Warren
Journal:  Thorax       Date:  1986-05       Impact factor: 9.139

2.  Waldenström's macroglobulinaemia in a bird breeder: a case history with pulmonary involvement and antibody activity of the monoclonal IgM to canary's droppings.

Authors:  J M James; J C Brouet; E Orvoenfrija; F Capron; J Brechot; F Danon; J Diebold; J Rochemaure; R Zittoun
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

3.  Multiple cystic lung lesions and autoimmune thrombocytopaenia developing after chemotherapy for pulmonary indolent B-cell lymphoma with plasmacytic differentiation.

Authors:  Hiroaki Tanaka; Chihiro Kuwabara; Yusuke Isshiki; Yoshio Suzuki
Journal:  BMJ Case Rep       Date:  2018-12-13

4.  Massive cardiac disease in a patient with Waldenstrom's macroglobulinaemia.

Authors:  L A Brawn; M A Parsons; P Allamby; L E Ramsay; F E Preston
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

5.  Waldenström's macroglobulinemia.

Authors:  C A Ries
Journal:  West J Med       Date:  1988-03

6.  A 72-year old man with low-grade non-Hodgkin's lymphoma, cold agglutinin hemolysis, rapidly progressive jaundice, hepatomegaly, and dyspnea.

Authors:  R W van der Hulst; J C Kluin-Nelemans; R Bieger; A Brand
Journal:  Ann Hematol       Date:  1993-11       Impact factor: 3.673

7.  Waldenström's macroglobulinemia. Report of an autopsy case presenting with a pulmonary manifestation.

Authors:  M Tsuji; Y Yoshii; T Taka; K Min; H Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

8.  Waldenström's macroglobulinemia: report of a case with pulmonary involvement and recurrent pneumococcal sepsis after pneumococcal vaccination.

Authors:  T E King; M I Schwarz; M Mathew
Journal:  J Natl Med Assoc       Date:  1984-02       Impact factor: 1.798

9.  Chylothorax as an Initial Manifestation of Waldenström macroglobulinemia.

Authors:  Natalia Rodriguez Botero; Andres Zerrate Misas; Kenny Mauricio Galvez Cardenas; Juan David Ramirez Quintero
Journal:  Cureus       Date:  2020-04-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.